Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep-Oct;79(5):597-600.
doi: 10.1016/j.mjafi.2021.06.022. Epub 2021 Sep 30.

Effects of high bilirubin level in pregnancy in Crigler-Najjar syndrome type 2: An extremely rare but important clinical entity to recognize

Affiliations
Case Reports

Effects of high bilirubin level in pregnancy in Crigler-Najjar syndrome type 2: An extremely rare but important clinical entity to recognize

Saurabh Bansal et al. Med J Armed Forces India. 2023 Sep-Oct.

Abstract

Crigler-Najjar is a rare genetic autosomal recessive disorder caused by deficiency of enzyme Uridine 5-Diphosphate Glucuronosyl Transferase (UDP-GT). We report the case of a 24-year-old female with two consecutive pregnancies with a high level of total bilirubin level of 15.1 mg/dl and a direct bilirubin level of 0.8 mg/dl during the first pregnancy. As she was diagnosed case of Crigler Najjar type 2, she was on phenobarbitone 60 mg daily. With careful monitoring, she continued with the same dose. We concluded that even with high bilirubin level (15.1 mg/dl) in pregnancy, no adverse effects to the baby and mother were seen.

Keywords: Crigler–Najjar type 2; Phenobarbitone; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors have none to declare.

Figures

Fig. 1
Fig. 1
Pedigree of family with Crigler-Najjar syndrome type II.
Fig. 2
Fig. 2
Relationship of weeks of gestation with bilirubin level.
Fig. 3
Fig. 3
Relationship of age of infant with bilirubin level.

Similar articles

References

    1. Chowdhury N, Chowdhury J: Crigler-Najjar syndrome. www.uptodate.com.
    1. Roy KP, Othman M, Pigazzi A: Crigler-Najjar syndrome. www.emedicine.com.
    1. Costa E. Hematologically important mutations: bilirubin UDP-glucuronosyltransferase gene mutations in Gilbert and CriglerNajjar syndromes. Blood Cells Mol Dis. 2006;36:77–80. - PubMed
    1. Seppen J., Bosma P.J., Goldhoorn B.G., et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994;94:2385–2391. - PMC - PubMed
    1. Ritter J.K., Yeatman M.T., Ferreira P., Owens I.S. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Invest. 1992;90:150–155. - PMC - PubMed

Publication types

LinkOut - more resources